Skip Navigation


NDT Advance Access originally published online on February 9, 2006
Nephrology Dialysis Transplantation 2006 21(7):1992-1993; doi:10.1093/ndt/gfl028
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/7/1992    most recent
gfl028v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ohtake, T.
Right arrow Articles by Moriya, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohtake, T.
Right arrow Articles by Moriya, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Case Report

Ticlopidine-induced lupus with renal involvement

Takayasu Ohtake1, Shuzo Kobayashi1, Koji Okamoto1, Machiko Oka1, Kyoko Maesato1, Takeo Yasu2 and Hidekazu Moriya1

1 Department of Nephrology, and Kidney & Dialysis Center and 2 Department of Pharmacy, Shonan Kamakura General Hospital, 1202-1 Yamazaki, Kamakura, 247-8533, Japan

Correspondence and offprint requests to: Takayasu Ohtake, MD, PhD, Department of Nephrology and Kidney and Dialysis Center, Shonan Kamakura General Hospital, 1202-1 Yamazaki, Kamakura, 247-8533, Japan. Email: ohtake@shonankamakura.or.jp

Keywords: drug-induced lupus; mesangial proliferative glomerulonephritis; renal involvement; systemic lupus erythematosus; ticlopidine

The first 10% of the full text of this article appears below.



   Introduction
 
Ticlopidine hydrochloride is a platelet aggregation inhibitor that is used for the prevention of vascular thrombosis. So far, only six cases of ticlopidine-induced lupus have been documented in the literature [1–3]. We report here a first case of ticlopidine-induced lupus with renal involvement.



   Case
 
A . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?